TP53 and cardiac hypertrophy: Nomura et al. (2018) found that in pressure overload–induced cardiac hypertrophy and heart failure mouse models, ERK1/2 and NRF1/2 are involved in the regulation of early cardiac hypertrophy, while p53 is mainly involved in cardiac remodeling in the decompensated phase.